These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20307592)

  • 1. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
    Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F; Vaman T; Gerlach B; Markendorf A; Gillard P; Devaster JM
    Vaccine; 2010 Feb; 28(7):1740-5. PubMed ID: 20034605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC
    Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009.
    Grills N; Piers LS; Barr I; Vaughan LM; Lester R; Magliano DJ; Shaw JE; Carnie JA
    Aust N Z J Public Health; 2010 Jun; 34(3):228-31. PubMed ID: 20618261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran.
    Moghadami M; Moattari A; Tabatabaee HR; Mirahmadizadeh A; Rezaianzadeh A; Hasanzadeh J; Ebrahimi M; Zamiri N; Alborzi A; Bagheri Lankarani K
    Iran J Immunol; 2010 Mar; 7(1):39-48. PubMed ID: 20371918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
    Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
    Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population exposure to a novel influenza A virus over three waves of infection.
    Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    J Clin Virol; 2011 Dec; 52(4):300-3. PubMed ID: 21924675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to influenza viruses in paediatric patients and their contacts at the onset of the 2009 pandemic in Mexico.
    Miranda-Novales G; Arriaga-Pizano L; Herrera-Castillo C; Pastelin-Palacios R; Valero-Pacheco N; Pérez-Toledo M; Ferat-Osorio E; Solórzano-Santos F; Vázquez-Rosales G; Espitia-Pinzón C; Zamudio-Lugo I; Meza-Chávez A; Klenerman P; Isibasi A; López-Macías C
    J Infect Dev Ctries; 2015 Mar; 9(3):259-66. PubMed ID: 25771463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of humoral immune responses to influenza viruses by using protein microarray.
    Koopmans M; de Bruin E; Godeke GJ; Friesema I; van Gageldonk R; Schipper M; Meijer A; van Binnendijk R; Rimmelzwaan GF; de Jong MD; Buisman A; van Beek J; van de Vijver D; Reimerink J
    Clin Microbiol Infect; 2012 Aug; 18(8):797-807. PubMed ID: 22212116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiologic survey for A/PR/8/34 (H1N1) virus from Chinese residents].
    Guo Y; Qi J; Wang M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):223-5. PubMed ID: 12526320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.